Orum Therapeutics Conference Call: Pipeline Strategy and Next Steps

Orum Therapeutics will hold a conference call to provide an update on its pipeline strategy, including the discontinuation of the ORM-6151 Phase 1 study, plans to advance its IND-cleared ORM-1153 program into a first-in-human Phase 1 trial, and priorities for the broader pipeline.

Event Details
Date: September 23, 2026
Time: 10:00 AM KST Webcast : (zoom link) *The link will be shared 30 minutes before the conference call.
Note: Please note that the conference call schedule may change due to company circumstances. If we need to make this change, we will update this notice. We ask for your understanding regarding this possibility.